EGFR and lung adenocarcinoma: EGFR, which encodes a receptor tyrosine kinase, is more frequently amplified in glioblastomas, whereas LRP1B, which encodes a low-density lipoprotein receptor related protein, is predominantly deleted in lung adenocarcinomas (LUAD).